Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bacterial Infections and Mycoses

  Free Subscription

Articles published in
Lancet
    July 2021
  1. VAN DE BEEK D, Brouwer MC, Koedel U, Wall EC, et al
    Community-acquired bacterial meningitis.
    Lancet. 2021 Jul 22. pii: S0140-6736(21)00883.
    >> Share

    June 2021
  2. DESHPANDE AA, Sharma V, Bansal R, Jagia P, et al
    Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade.
    Lancet. 2021;397:e15.
    >> Share

    May 2021
  3. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    >> Share

    April 2021
  4. WALTER KS, Martinez L, Arakaki-Sanchez D, Sequera VG, et al
    The escalating tuberculosis crisis in central and South American prisons.
    Lancet. 2021 Apr 8. pii: S0140-6736(20)32578.
    >> Share

    March 2021
  5. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    >> Share

  6. LANE R
    Nicole Salazar-Austin: emerging tuberculosis-HIV research leader.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00587.
    >> Share

  7. KHO SS, Ho YF, Chan SK, Tie ST, et al
    Mediastinal melioidosis masquerading as malignancy of the lung.
    Lancet. 2021;397:e8.
    >> Share

    February 2021
  8. MAERTENS JA, Rahav G, Lee DG, Ponce-de-Leon A, et al
    Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
    Lancet. 2021;397:499-509.
    >> Share

  9. THORNTON J
    Hopes for trachoma control in South Sudan.
    Lancet. 2021;397:461.
    >> Share

    January 2021
  10. MACLEAN E, Bigio J, Singh U, Klinton JS, et al
    Global tuberculosis awards must do better with equity, diversity, and inclusion.
    Lancet. 2021;397:192-193.
    >> Share

    November 2020
  11. GILBERT L, Miller K, Medeiros D, Tsatoumas M, et al
    A disease disregards anatomical planes: actinomycosis and an intrauterine device.
    Lancet. 2020;396:1766.
    >> Share

  12. FORD AC, Mahadeva S, Carbone MF, Lacy BE, et al
    Functional dyspepsia.
    Lancet. 2020;396:1689-1702.
    >> Share

    September 2020
  13. BURKI T
    Inappropriate behaviour claims at Stop TB prompt review.
    Lancet. 2020;396:876.
    >> Share

  14. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    >> Share

  15. DE BENEDICTIS FM, Kerem E, Chang AB, Colin AA, et al
    Complicated pneumonia in children.
    Lancet. 2020;396:786-798.
    >> Share

    August 2020
  16. BISSON GP, Bastos M, Campbell JR, Bang D, et al
    Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
    Lancet. 2020;396:402-411.
    >> Share

    June 2020
  17. LADHANI SN, Lucidarme J, Parikh SR, Campbell H, et al
    Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis.
    Lancet. 2020;395:1865-1877.
    >> Share

  18. WITHINGTON P
    Journal of a plague year.
    Lancet. 2020;395:1754-1755.
    >> Share

    May 2020
  19. BATE J
    The worst is not, so long as we can say "this is the worst".
    Lancet. 2020;395:1479-1480.
    >> Share

    April 2020
  20. THORNHILL MH, Dayer MJ, Nicholl J, Prendergast BD, et al
    An alarming rise in incidence of infective endocarditis in England since 2009: why?
    Lancet. 2020;395:1325-1327.
    >> Share


  21. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
    >> Share

  22. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    >> Share

  23. THE LANCET
    A new roadmap for meningitis.
    Lancet. 2020;395:1230.
    >> Share

  24. JOHNSON PDR
    Buruli ulcer: cured by 8 weeks of oral antibiotics?
    Lancet. 2020;395:1231-1232.
    >> Share

  25. PHILLIPS RO, Robert J, Abass KM, Thompson W, et al
    Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Lancet. 2020;395:1259-1267.
    >> Share

  26. BOYCE N
    Bills of Mortality: tracking disease in early modern London.
    Lancet. 2020;395:1186-1187.
    >> Share

    March 2020
  27. MARTINEZ L, Cords O, Horsburgh CR, Andrews JR, et al
    The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
    Lancet. 2020;395:973-984.
    >> Share

  28. SAHU S, Ditiu L, Lawson L, Ntoumi F, et al
    UN General Assembly tuberculosis targets: are we on track?
    Lancet. 2020;395:928-930.
    >> Share

  29. CAMPBELL JR, Bastos ML
    No time to waste: preventing tuberculosis in children.
    Lancet. 2020;395:924-926.
    >> Share

  30. KIM HY, Heysell SK, Mpagama S, Marais BJ, et al
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:783.
    >> Share

  31. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Challenging the management of drug-resistant tuberculosis - Authors' reply.
    Lancet. 2020;395:783-784.
    >> Share

  32. GASKELL KM, Moore DAJ
    Challenging the management of drug-resistant tuberculosis.
    Lancet. 2020;395:782-783.
    >> Share

    February 2020
  33. DESGRANGES F, Coste AT, Wernly D, Dufour J, et al
    Immunosuppressed gardener pricked by roses grows Legionella longbeachae.
    Lancet. 2020;395:604.
    >> Share

  34. LANE R
    Hans Kluge: charismatic, new WHO Regional Director for Europe.
    Lancet. 2020;395:329.
    >> Share

    January 2020
  35. ALLEGRETTI JR, Mullish BH
    Faecal microbiota transplantations and urinary tract infections - Authors' reply.
    Lancet. 2020;395:271.
    >> Share

    November 2019
  36. MAKRI A
    Progress lags on vaccines to beat antimicrobial resistance.
    Lancet. 2019;394:1793-1794.
    >> Share

  37. WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
    The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate.
    Lancet. 2019;394:1836-1878.
    >> Share

  38. VARO R, Bila R, Saavedra B, Sitoe A, et al
    Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula.
    Lancet. 2019;394:1651.
    >> Share

    October 2019
  39. THE LANCET
    End the tuberculosis emergency: a promise is not enough.
    Lancet. 2019;394:1482.
    >> Share

  40. SINGER M, Inada-Kim M, Shankar-Hari M
    Sepsis hysteria: excess hype and unrealistic expectations.
    Lancet. 2019;394:1513-1514.
    >> Share

  41. MALLUCCI CL, Jenkinson MD, Conroy EJ, Hartley JC, et al
    Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation.
    Lancet. 2019;394:1530-1539.
    >> Share

  42. RAY S, Anand K
    Reduce the delay in tuberculosis diagnosis in India.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32476.
    >> Share

  43. THANGARAJU P, Venkatesan S
    A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
    Lancet. 2019;394:1450.
    >> Share

  44. MAHARAJ S, Seemungal T, McKee M
    A perfect storm in the Caribbean requires a concerted response.
    Lancet. 2019;394:1409.
    >> Share

  45. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    >> Share

    September 2019
  46. KOKO AM, Ismail NJ, Lasseini A, Shehu BB, et al
    Remarkable recovery in an infant with brain abscesses.
    Lancet. 2019;394:1191.
    >> Share

  47. REUTER A, Hughes J, Furin J
    Challenges and controversies in childhood tuberculosis.
    Lancet. 2019;394:967-978.
    >> Share

  48. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Management of drug-resistant tuberculosis.
    Lancet. 2019;394:953-966.
    >> Share

  49. THE LANCET
    Tuberculosis needs accelerated and continued attention.
    Lancet. 2019;394:896.
    >> Share

  50. KOSKENVUO L, Lehtonen T, Koskensalo S, Rasilainen S, et al
    Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial.
    Lancet. 2019;394:840-848.
    >> Share

    August 2019
  51. HAGHBAYAN H, Ballios BG, Coomes EA
    Management of rheumatic mitral stenosis.
    Lancet. 2019;394:637.
    >> Share

  52. MCCARRON EP, Monaghan M, Sreenivasan S
    Management of rheumatic mitral stenosis.
    Lancet. 2019;394:636-637.
    >> Share

  53. REID MJA, Goosby E
    A tuberculosis-free world: is it a delusion? - Authors' reply.
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31411.
    >> Share

  54. ATRE S
    A tuberculosis-free world: is it a delusion?
    Lancet. 2019 Aug 12. pii: S0140-6736(19)31623.
    >> Share

  55. ALLEGRETTI JR, Mullish BH, Kelly C, Fischer M, et al
    The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
    Lancet. 2019;394:420-431.
    >> Share

  56. OLIVIER-GOUGENHEIM L, Freychet C, Collardeau-Frachon S, Roure-Sobas C, et al
    A quest for Q fever.
    Lancet. 2019;394:419.
    >> Share

  57. THE LANCET
    Building capacity in Africa's national science academies.
    Lancet. 2019;394:360.
    >> Share

    July 2019
  58. BASHAM CA, Elias B, Orr P
    Tuberculosis elimination in Canada.
    Lancet. 2019;394:300-301.
    >> Share

  59. MENZIES D, Benedetti A, Migliori GB, Nahid P, et al
    Multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2019;394:299-300.
    >> Share

  60. CHIANG CY, Van Deun A, Trebucq A, Piubello A, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:299.
    >> Share

  61. CAMINERO JA, Garcia-Basteiro AL, Rendon A
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298.
    >> Share

  62. NYANG'WA BT, Berry C, Fielding K, Nunn AJ, et al
    Multidrug-resistant tuberculosis.
    Lancet. 2019;394:298-299.
    >> Share

  63. CARLSON CJ, Mendenhall E
    Preparing for emerging infections means expecting new syndemics.
    Lancet. 2019;394:297.
    >> Share

  64. LAVOIE PM, Popescu CR, Molyneux EM, Wynn JL, et al
    Rethinking management of neonates at risk of sepsis.
    Lancet. 2019;394:279-281.
    >> Share

  65. MOAZEN B, Assari S, Neuhann F, Stover H, et al
    The guidelines on infection control in prisons need revising.
    Lancet. 2019;394:301-302.
    >> Share

  66. WANG HH, Lau E, Horton R, Jiang B, et al
    The Wakley-Wu Lien Teh Prize Essay 2019: telling the stories of Chinese doctors.
    Lancet. 2019;394:11.
    >> Share

    June 2019

  67. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.
    Lancet. 2019 Jun 27. pii: S0140-6736(19)30721.
    >> Share

  68. KNIGHT M, Chiocchia V, Partlett C, Rivero-Arias O, et al
    Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.
    Lancet. 2019;393:2395-2403.
    >> Share

  69. MORI Y, Katasako A, Matsunaga S, Matono T, et al
    Tetanus: remember to vaccinate.
    Lancet. 2019;393:2331.
    >> Share

    May 2019
  70. RYAN JM, Feder HM Jr
    Dog licks baby. Baby gets Pasteurella multocida meningitis.
    Lancet. 2019;393:e41.
    >> Share

  71. USHER AD
    Low-cost pneumonia vaccine breaks into global market.
    Lancet. 2019;393:2025-2026.
    >> Share

  72. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    >> Share

  73. KIRKCALDY RD, Workowski KA
    Gentamicin as an alternative treatment for gonorrhoea.
    Lancet. 2019 May 2. pii: S0140-6736(19)30244.
    >> Share

  74. ROSS JDC, Brittain C, Cole M, Dewsnap C, et al
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.
    >> Share

    April 2019
  75. ZHONG D, Yi Y, Lin C
    A kidney changes size: first increasing and then decreasing.
    Lancet. 2019;393:1641.
    >> Share

  76. YEN LM, Thwaites CL
    Tetanus.
    Lancet. 2019;393:1657-1668.
    >> Share

  77. KLUGMAN KP, Rodgers GL
    Population versus individual protection by pneumococcal conjugate vaccination.
    Lancet. 2019 Apr 15. pii: S0140-6736(19)30039.
    >> Share

  78. HAMMITT LL, Etyang AO, Morpeth SC, Ojal J, et al
    Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
    Lancet. 2019 Apr 15. pii: S0140-6736(18)33005.
    >> Share

  79. PAN D, Arkell P, Stone NRH, Parkinson B, et al
    Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids.
    Lancet. 2019;393:1536.
    >> Share

  80. HONIGSBAUM M
    Disease X and other unknowns.
    Lancet. 2019;393:1496-1497.
    >> Share

    March 2019
  81. ABUBAKAR I, Plasencia A, Barnighausen T, Froeschl G, et al
    Horizon Europe: towards a European agenda for global health research and innovation.
    Lancet. 2019;393:1272-1273.
    >> Share

  82. MIMOZ O, Guenezan J
    No benefit of chlorhexidine bathing in non-critical care units.
    Lancet. 2019;393:1179-1180.
    >> Share

  83. HUANG SS, Septimus E, Kleinman K, Moody J, et al
    Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.
    Lancet. 2019;393:1205-1215.
    >> Share

  84. ZUCCALA E, Horton R
    Time to bring tuberculosis out of the shadows.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30486.
    >> Share

  85. KI-MOON B
    Building a tuberculosis-free world on a foundation of universal health coverage.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30433.
    >> Share

  86. ZAROCOSTAS J
    Nandita Venkatesan: a voice of hope for tuberculosis survivors.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30582.
    >> Share

  87. NADDA JP
    India's leadership to end tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30487.
    >> Share

  88. KUMAR A
    Picturing health: it's time to act on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30583.
    >> Share

  89. WEBSTER P
    Inuit research raises concerns about tuberculosis eradication.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30681.
    >> Share

  90. REID MJA, Arinaminpathy N, Bloom A, Bloom BR, et al
    Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30024.
    >> Share

  91. FURIN J, Cox H, Pai M
    Tuberculosis.
    Lancet. 2019 Mar 20. pii: S0140-6736(19)30308.
    >> Share

  92. WATTS G
    Christine Sekaggya-Wiltshire: prizewinner in HIV-tuberculosis research.
    Lancet. 2019 Mar 19. pii: S0140-6736(19)30644.
    >> Share

  93. FADEL SA, Boschi-Pinto C, Yu S, Reynales-Shigematsu LM, et al
    Trends in cause-specific mortality among children aged 5-14 years from 2005 to 2016 in India, China, Brazil, and Mexico: an analysis of nationally representative mortality studies.
    Lancet. 2019;393:1119-1127.
    >> Share

  94. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    >> Share

  95. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    >> Share

  96. OLMEDO-RENEAUM A, Garcia-Juarez I, Toapanta-Yanchapaxi L, De La Pena-Lopez R, et al
    Rogue "stem cell clinic" leads to Mycobacterium abscessus infection.
    Lancet. 2019;393:918.
    >> Share

    February 2019
  97. STORY A, Aldridge RW, Smith CM, Garber E, et al
    Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.
    Lancet. 2019 Feb 21. pii: S0140-6736(18)32993.
    >> Share

  98. FRASER H, Keshavjee S
    Video-observed therapy for tuberculosis: strengthening care.
    Lancet. 2019 Feb 21. pii: S0140-6736(19)30293.
    >> Share

  99. KUMAR A, Lambert S, Lockwood DNJ
    Picturing health: a new face for leprosy.
    Lancet. 2019;393:629-638.
    >> Share

  100. THE LANCET
    Abandoning the stigma of leprosy.
    Lancet. 2019;393:378.
    >> Share

  101. GOSTIN L, Phelan A, Coutinho AG, Eccleston-Turner M, et al
    Ebola in the Democratic Republic of the Congo: time to sound a global alert?
    Lancet. 2019 Feb 1. pii: S0140-6736(19)30243.
    >> Share

    January 2019
  102. CHEKHCHAR M, Hajji I, Madiq B, Darfaoui Z, et al
    Mitral stenosis found after eye problem.
    Lancet. 2019;393:275.
    >> Share

  103. BARNETT R
    Cholera.
    Lancet. 2019;393:218.
    >> Share


  104. Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32221.
    >> Share

  105. DOYLE LW, Cheong JLY
    Does bovine lactoferrin prevent late-onset neonatal sepsis?
    Lancet. 2019 Jan 8. pii: S0140-6736(18)32390.
    >> Share

  106. FERRY G
    Dorothy Stopford Price and the control of tuberculosis in Ireland.
    Lancet. 2019;393:20.
    >> Share

    December 2018
  107. SAVIOLI L, Daumerie D
    WHO leadership is essential for the elimination of NTDs.
    Lancet. 2018;390:2765.
    >> Share

  108. YAQUB F
    2017: a year in review.
    Lancet. 2018;390:2753-2754.
    >> Share

  109. THE LANCET
    Our responsibility to protect the Rohingya.
    Lancet. 2018;390:2740.
    >> Share

  110. BLUMENTHAL KG, Peter JG, Trubiano JA, Phillips EJ, et al
    Antibiotic allergy.
    Lancet. 2018 Dec 14. pii: S0140-6736(18)32218.
    >> Share

  111. OLSAVSZKY V, Geraud C
    Liaison leads to solitary syphilitic chancre on the neck.
    Lancet. 2018;392:2397.
    >> Share

  112. VAN DER HEIJDE D, Baraliakos X, Gensler LS, Maksymowych WP, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2378-2387.
    >> Share

  113. MEASE P, Coates LC, Helliwell PS, Stanislavchuk M, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2367-2377.
    >> Share

  114. MBONYE AK, Sekamatte M
    Disease outbreaks and reporting in Uganda.
    Lancet. 2018;392:2347-2348.
    >> Share

    November 2018

  115. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1859-1922.
    >> Share

  116. MARMORA L, Casas CP, Grubb I, McClure C, et al
    Long-acting technologies for infectious diseases in LMICs.
    Lancet. 2018;392:1610-1611.
    >> Share

  117. GRANICH R
    Is the global tuberculosis control strategy too big to fail?
    Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
    >> Share

    October 2018
  118. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    >> Share

  119. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    >> Share

  120. MARKS F, Kim JH, Rakotozandrindrainy R
    Madagascar should introduce typhoid conjugate vaccines now.
    Lancet. 2018;392:1309-1310.
    >> Share

  121. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    >> Share

  122. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    >> Share

  123. THE LANCET
    Congenital syphilis in the USA.
    Lancet. 2018;392:1168.
    >> Share

  124. COUSINS S
    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    >> Share

    September 2018
  125. MAKONI M
    Inside Zimbabwe's efforts to tame cholera.
    Lancet. 2018;392:e8.
    >> Share

  126. MARAIS B, Zumla A
    Advancing global tuberculosis control after the UNGA-HLM.
    Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
    >> Share

  127. THE LANCET
    Monkeypox contacts: a puzzling problem.
    Lancet. 2018;392:986.
    >> Share

  128. TRIPATHI M, Mohindra S
    Rhinocerebral aspergillosis.
    Lancet. 2018;392:e8.
    >> Share

  129. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    >> Share

  130. FARMER PE
    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    >> Share

  131. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    >> Share

    August 2018
  132. COUSINS S
    Experts fear a resurgence of leprosy in India.
    Lancet. 2018;392:624-625.
    >> Share

  133. THWAITES GE, Szubert A, Walker AS
    Rifampicin in treating S aureus bacteraemia - Authors' reply.
    Lancet. 2018;392:555-556.
    >> Share

  134. RIEG S, Kern WV, Soriano A
    Rifampicin in treating S aureus bacteraemia.
    Lancet. 2018;392:554-555.
    >> Share

  135. THE LANCET
    Zika-associated health and development problems in children.
    Lancet. 2018;392:532.
    >> Share

  136. MBOI N, Murty Surbakti I, Trihandini I, Elyazar I, et al
    On the road to universal health care in Indonesia, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2018;392:581-591.
    >> Share

  137. BURZA S, Croft SL, Boelaert M
    Leishmaniasis.
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    >> Share

  138. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    >> Share

  139. THE LANCET
    Introducing EU-wide surveillance of Lyme neuroborreliosis.
    Lancet. 2018;392:452.
    >> Share

    July 2018
  140. WALLACE DJ, Furie RA, Tanaka Y, Kalunian KC, et al
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:222-231.
    >> Share

  141. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    >> Share

  142. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    >> Share

  143. SEALE AC, Agarwal R
    Improving management of neonatal infections.
    Lancet. 2018;392:100-102.
    >> Share

  144. KARTHIKEYAN G, Guilherme L
    Acute rheumatic fever.
    Lancet. 2018;392:161-174.
    >> Share

  145. SAHA SK, Schrag SJ, El Arifeen S, Mullany LC, et al
    Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study.
    Lancet. 2018;392:145-159.
    >> Share

    June 2018
  146. KRAEF C, Arand J, Veletzky L, Schafer H, et al
    Schistosomiasis detected during appendectomy.
    Lancet. 2018;391:2546.
    >> Share

  147. CECCONI M, Evans L, Levy M, Rhodes A, et al
    Sepsis and septic shock.
    Lancet. 2018 Jun 21. pii: S0140-6736(18)30696.
    >> Share

  148. XIE X, Bai J
    Concentric circles in left atrium.
    Lancet. 2018;391:2448.
    >> Share

  149. SALAMA PJ, Embarek PKB, Bagaria J, Fall IS, et al
    Learning from listeria: safer food for all.
    Lancet. 2018;391:2305-2306.
    >> Share

  150. THE LANCET
    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    >> Share


  151. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
    Lancet. 2018;391:2236-2271.
    >> Share

    May 2018
  152. CHATTOPADHYAY A, Sharma A, Gupta K, Jain S, et al
    The Phemister triad.
    Lancet. 2018;391:e20.
    >> Share

  153. THE LANCET
    Balancing treatment with resistance in UTIs.
    Lancet. 2018;391:1966.
    >> Share

  154. QADRI F, Azad AK, Flora MS, Khan AI, et al
    Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh.
    Lancet. 2018;391:1877-1879.
    >> Share

  155. LESSLER J, Moore SM, Luquero FJ, McKay HS, et al
    Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.
    Lancet. 2018;391:1908-1915.
    >> Share

  156. MINTZ E
    Taking aim at cholera.
    Lancet. 2018;391:1868-1870.
    >> Share

  157. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    >> Share

  158. GUENOT M
    Roger Glass: celebrating the Fogarty at 50.
    Lancet. 2018;391:1765.
    >> Share

    April 2018
  159. CHU DK, Kim LH, Young PJ, Zamiri N, et al
    Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
    Lancet. 2018;391:1693-1705.
    >> Share

  160. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    >> Share

  161. MITJA O, Godornes C, Houinei W, Kapa A, et al
    Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
    Lancet. 2018;391:1599-1607.
    >> Share

  162. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    >> Share

    March 2018
  163. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    >> Share

  164. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    >> Share

  165. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    >> Share

  166. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    >> Share

  167. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    >> Share

  168. MCCALL C
    Rheumatic heart disease in the Pacific island nations.
    Lancet. 2018;391:926.
    >> Share

    February 2018
  169. BURKI T
    End of a cholera epidemic in South Sudan declared.
    Lancet. 2018;391:647.
    >> Share

  170. MUHSEN K, Green MS, Soskolne V, Neumark Y, et al
    Inequalities in non-communicable diseases in Israel - Authors' reply.
    Lancet. 2018;391:537.
    >> Share

  171. WATTS N, Amann M, Ayeb-Karlsson S, Belesova K, et al
    The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health.
    Lancet. 2018;391:581-630.
    >> Share

  172. SMAJS D, Pospisilova P
    Macrolide resistance in yaws.
    Lancet. 2018 Feb 7. pii: S0140-6736(18)30205.
    >> Share

  173. HONIGSBAUM M
    Superbugs and us.
    Lancet. 2018;391:420.
    >> Share

    January 2018
  174. ZAROCOSTAS J
    Mega-crisis in DR Congo.
    Lancet. 2018;391:297-298.
    >> Share

  175. THE LANCET
    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    >> Share

  176. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    >> Share

    December 2017
  177. HOLLAND TL, Fowler VG Jr
    Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)33294.
    >> Share

  178. THWAITES GE, Scarborough M, Szubert A, Nsutebu E, et al
    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)32456.
    >> Share

    September 2017
  179. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    >> Share

    July 2017
  180. YACOUB M, Mayosi B, ElGuindy A, Carpentier A, et al
    Eliminating acute rheumatic fever and rheumatic heart disease.
    Lancet. 2017;390:212-213.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016